Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l’étude CAN-BIND-1
ObjectivesCurrent pharmacological antidepressant treatments suffer from low remission rates and slow initiation of therapeutic effects. In addition, the development of new antidepressant treatments is confounded by the lack of consensus on efficient and valid neurophysiological targets. Temporal complexity is an alternative measure of dynamic brain activity that estimates brain signal variability at several timescales. It can be easily extracted from non-invasive brain recordings and provides new insights into pathophysiological mechanisms. We aim to assess the potential of brain temporal complexity as a novel neuromarker to predict the effectiveness of antidepressant treatments.MethodWe measured longitudinal changes in temporal complexity of electroencephalography signals in patients undergoing 8 weeks of escitalopram treatment through a Canadian Biomarker Integration Network in Depression (CAN-BIND) trial.ResultsAs early as 2 weeks after the start of treatment, reduction of complexity in fine timescales was associated with improvement in depressive symptoms. After 8 weeks of treatment, the treatment-related effect shifted towards an increase in coarse timescale complexity, linked to symptom improvement.ConclusionsThese results suggest a relative shift away from local, segregated information processing, measured by complexity at fine timescales, in the short term, potentially in favour of a higher long-range communication across networks, as indicated by higher complexity measures at coarse timescales in the long term. Further research into the modulation of multiscale temporal complexity by antidepressant treatments could open new possibilities for faster-acting and more efficient treatments.
Authors
- Gustavo Turecki (ORCID: https://orcid.org/0000-0003-4075-2736)
- Prabhjot Dhami
- Faranak Farzan (ORCID: https://orcid.org/0000-0001-9249-2994)
- Raaj Chatterjee
- Jane Allyson Foster (ORCID: https://orcid.org/0000-0002-8579-4705)
- Stephen R. Arnott (ORCID: https://orcid.org/0000-0002-0616-7771)
- Benjamin Schwartzmann (ORCID: https://orcid.org/0000-0003-2227-4072)
- Rudolf Uher (ORCID: https://orcid.org/0000-0002-2998-0546)
- Sidney H. Kennedy (ORCID: https://orcid.org/0000-0001-5339-7185)
- Yasaman Vaghei (ORCID: https://orcid.org/0000-0003-4357-8438)
- Sravya Atluri
- Benicio Noronha Frey (ORCID: https://orcid.org/0000-0001-8267-943X)
- Chloé Stengel (ORCID: https://orcid.org/0000-0002-9331-3801)
- Raymond Lam
- Daniel J. Müller (ORCID: https://orcid.org/0000-0003-4978-4400)
- Sagar V. Parikh
- Claudio N. Soares
- Susan Rotzinger
- Pierre Blier
- Roumen Milev
Institutions
- Dalhousie University (CA)
- Centre for Addiction and Mental Health (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- Simon Fraser University (CA)
- University of Toronto (CA)
- Queen's University (CA)
- University of Michigan (US)
- Douglas Mental Health University Institute (CA)
- Ontario Shores Centre for Mental Health Sciences (CA)
- Southwestern Medical Center (US)
- Indoc Research (CA)
- Unity Health Toronto
- McGill University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- The University of Texas Southwestern Medical Center (US)
- McMaster University (CA)
Publication Details
- Journal
- The Canadian Journal of Psychiatry
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1177/07067437251408188
- Primary Topic
- Functional Brain Connectivity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00